Provider of immunotherapies and vaccine services intended to help in the treatment of diseases. The company's services are dedicated to building a technology platform for improved, efficient medicines through disruptive vaccine development technology that produces vaccines rapidly, enabling patients to access medicines that help in treatment of numerous diseases.
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
4. Accelerator/Incubator | 22-Aug-2015 | 00000 | Completed | Generating Revenue | ||
3. Grant | 01-Jan-2012 | 00000 | 00000 | Completed | Generating Revenue | |
2. Seed Round | $419K | Completed | Generating Revenue | |||
1. Capitalization | $419K | $419K | Completed | Generating Revenue |
Name | Title | Board Seat | Contact Info |
---|---|---|---|
Vishwas Joshi Ph.D | Managing Director | ||
Shailendra Maheshwari | Board Member & Promoter Director | ||
Shruti Joshi | Board Member & Promoter Director |
Name | Representing | Role | Since |
---|---|---|---|
Manisha Premnath Ph.D | Self | Board Member | 000 0000 |
Shailendra Maheshwari | Seagull Biosolutions | Board Member & Promoter Director | 000 0000 |
Shruti Joshi | Seagull Biosolutions | Board Member & Promoter Director | 000 0000 |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Venture Center | Venture Capital | Minority | 000 0000 | 000000 0 | |
Bill & Melinda Gates Foundation | Not-For-Profit Venture Capital | 000 0000 | 000000 0 | ||
Technology Development Board | Limited Partner | Minority | 000 0000 | 000000 0 |